Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Registry for ELAD system follow-up (VTI-207)
NCT01452295Phase 3Withdrawn
- Sponsor
- Vital Therapies, Inc.
- Start
- Jun 2010
- Primary completion
- Sep 2012
- Modality
- Cell Therapies, Device-based Delivery
01
Overview
A Phase 3 trial of ELAD in acute-on-chronic hepatitis, alcoholic hepatitis (AH), sponsored by Vital Therapies, Inc.. Planned start Jun 2010; status: withdrawn.
02
Drugs
ELAD
03
Conditions
acute-on-chronic hepatitisalcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT01452295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452295.